# Syncell

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/syncell

- Industry: Biotechnology
- Headquarters: Watertown, US
- Website: www.syncell.com
- Total disclosed funding: $15M
- Latest round: Series A (Dec 11, 2024)
- Investors on record: 1

## About

Based in Massachusetts, US, and founded in 2020, Syncell, Inc. is a biotechnology company that provides a spatial biology system for spatial proteomics and biomarker discovery. In December 2024, Syncell, Inc. raised TWD 15 million in series A funding led by Taiwania Capital.

Syncell, Inc. focuses on spatial proteomics with its main product, the Microscoop platform. The firm platform helps discover proteins at the cellular and subcellular levels, working well with special reagent kits like Synlight and Synpull. These tools help with spatial protein purification and proteomic analysis, focusing on identifying different cell types and biomarkers linked to various diseases. Syncell serves a range of clients, including universities, biotech companies, and pharmaceutical firms, all involved in research in areas like cell biology, neuroscience, and cancer.

The company plans to use the December 2024 funding to expand and accelerate global commercialization and support for its Microscoop platform.

## Funding rounds

- Series A, Dec 11, 2024, $15M — Taiwania Capital

## Investors

- Taiwania Capital (https://capitalatlas.ai/funds/taiwania-capital) — Series A